You are here

Acute Stroke Treatment: Addressing Missed Opportunities Virtual Grand Rounds

View Webinar

Original Program Date: September 17, 2013
Estimated Time to Complete: 1 hour

This activity is jointly sponsored by Medical Education Resources and National Stroke Association.

Accreditation for this program has expired. This program is for informational purposes.

Program Overview

Stroke is one of the leading causes of long-term adult disability, affecting approximately 795,000 people each year in the U.S. Many studies have identified patient failure to arrive at the hospital in time for treatment following the stroke symptom onset as the key barrier to increasing rates of thrombolytic treatment. Stroke center personnel agree that public lack of knowledge about the appropriate response to stroke symptoms is a key barrier to stroke treatment—a barrier that has proven intransigent to many and diverse interventions.

The Acute Stroke Treatment: Addressing Missed Opportunities virtual grand rounds program will provide a succinct update on key new evidence about acute stroke care, especially care in the emergency department, where the speed and accuracy of diagnosis and treatment can have profound long-term impacts on patient quality of life.

Purpose Statement

To educate learners on the most common missed opportunities in acute ischemic stroke in an effort to increase diagnosis and treatment to improve patient outcomes.

Goals and Learning Objectives

The goal of the Acute Stroke Treatment: Addressing Missed Opportunities virtual grand rounds activity is to promote the reduction in time to treat and facilitate increased treatment rates for acute ischemic stroke. Through participation in these activities, learners will be able to:

  • Discuss the rationale for earliest possible treatment
  • Identify potential targets for improving times to treat in the emergency department
  • Describe characteristics that can lead to delayed or missed diagnosis and/or treatment
  • Discuss the rationale for evolving and modifying exclusion criteria, based on evidence
  • Identify relevant targets for improvement within their respective hospitals, to either decrease time to treat or increase rates of treatment

Target Audience

The target audience for the Acute Stroke Treatment: Addressing Missed Opportunities virtual grand rounds activity includes emergency medicine physicians and nurses, neurologists and neuroscience nurses. Because in-hospital strokes account for approximately 15 percent of all strokes, the program also will target ICU and other nurses, hospitalists and other hospital-based professionals who care for stroke patients.

For questions regarding this activity, please contact Medical Education Resources at or National Stroke Association at


Edward Jauch, MD, MS
Professor, Interim Chief, Division of Emergency Medicine
Associate Vice Chair, Research
Department of Medicine Professor
Department of Neurosciences - Medical University of South Carolina Charleston, S.C.

David Liebeskind, MD, FAHA, FAAN
Professor of Neurology
Neurology Director, Stroke Imaging Co-medical and Co-technical Director, UCLA Cerebral Blood Flow Laboratory Program
Director, Stroke and Vascular Neurology Residency
Associate Neurology Director, UCLA Stroke Center
Los Angeles, Calif.

Disclosure of Conflict of Interest
Medical Education Resources ensures balance, independence, objectivity and scientific rigor in all its educational activities. In accordance with this policy, Medical Education Resources identifies conflicts of interest with its instructors, content managers and other individuals who are in a position to control the content of an activity. Medical Education Resources resolves conflicts to ensure that all scientific research referred to, reported or used in a CME activity conforms to the generally accepted standards of experimental design, data collection and analysis. Medical Education Resources is committed to providing its learners with high-quality CME activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.

Faculty Disclosures

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:

Name of Faculty Reported Financial Relationship
Dr. Ed Jauch Consultant Roche Diagnostic
Dr. David Liebeskind Consultant NIH-NINDS, Stryker, Covidien, CoAxia
Kim Bova, BSN, RN, CCRN, CEN No financial relationship to disclose

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Content Managers Reported Financial Relationship
Amy Jensen, National Stroke Association No financial relationship to disclose
Michelle Murdock, Consultant No financial relationship to disclose
Veronda Smith, FNP-BC No financial relationship to disclose
Julie Johnson, PharmD No financial relationship to disclose


The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, National Stroke Association, and/or Genentech and Penumbra. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, National Stroke Association and/or Genentech and Penumbra. MER’s ANCC accreditation status does not imply endorsement by MER or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

System requirements:

PC-based attendees—Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista or newer.
Macintosh®-based attendees—Required: Mac OS X 10.4 (Tiger®) or newer.

To view MER’s Privacy Policy:

The Acute Stroke Treatment: Addressing Missed Opportunities virtual grand rounds enduring activity is supported by an educational grant from Genentech, Inc.

Additional Resources

Find a Support Group


Get Involved


For over 30 years we have been the trusted source for free resources and education to the stroke community. Together, we empower survivors and their circle of care to thrive after stroke. Make your tax-deductible donation today to support the growing needs of the stroke community.